TABLE OF CONTENTS
| | | | Volume 21, Issue 11 (November 2014) | | In this issue Original Articles
Also new AOP | | | | | Advertisement | | Scientific Data - We will be attending the Society for Neuroscience conference on 16th - 19th November. Come and see us at booth 201. | | | | | | Original Articles | Top | | Neutrophil:lymphocyte ratios and serum cytokine changes after hepatic artery chimeric antigen receptor-modified T-cell infusions for liver metastasesA Saied, L Licata, R A Burga, M Thorn, E McCormack, B F Stainken, E O Assanah, P D Khare, R Davies, N J Espat, R P Junghans and S C Katz Cancer Gene Ther 2014 21: 457-462; advance online publication, October 3, 2014; 10.1038/cgt.2014.50 Abstract | Full Text | | | | Intravenously injected Newcastle disease virus in non-human primates is safe to use for oncolytic virotherapyP R A Buijs, G van Amerongen, S van Nieuwkoop, T M Bestebroer, P R W A van Run, T Kuiken, R A M Fouchier, C H J van Eijck and B G van den Hoogen Cancer Gene Ther 2014 21: 463-471; advance online publication, September 26, 2014; 10.1038/cgt.2014.51 Abstract | Full Text | | | | Bortezomib sensitizes non-small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicityM Ando, V Hoyos, S Yagyu, W Tao, C A Ramos, G Dotti, M K Brenner and L Bouchier-Hayes Cancer Gene Ther 2014 21: 472-482; advance online publication, October 17, 2014; 10.1038/cgt.2014.53 Abstract | Full Text | | | | Measles Edmonston vaccine strain derivatives have potent oncolytic activity against osteosarcomaE Domingo-Musibay, C Allen, C Kurokawa, J J Hardcastle, I Aderca, P Msaouel, A Bansal, H Jiang, T R DeGrado and E Galanis Cancer Gene Ther 2014 21: 483-490; advance online publication, November 14, 2014; 10.1038/cgt.2014.54 Abstract | Full Text | | | | Knockdown of EGFR inhibits growth and invasion of gastric cancer cellsY Zhen, L Guanghui and Z Xiefu Cancer Gene Ther 2014 21: 491-497; advance online publication, November 14, 2014; 10.1038/cgt.2014.55 Abstract | Full Text | | | | | Advertisement | | Nature Collections Clinical applications of next-generation sequencing
This special Collection highlights the breadth of applications of next-generation sequencing technologies in the clinic and the importance of the insights that are being gained through these methods to improve health.
Produced with support from Life Technologies, a brand of Thermo Fisher Scientific. | | | | | | | | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. | | | | |
No comments:
Post a Comment